New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics

April 2015

Welcome to the April 2015 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the April issue!

The PharmSource Team


New PharmSource Lead Sheet Capabilities

Trend Reports Graphing Feature:

  • This feature allows you to quickly graph either lead data or financing data to identify trends over time. To access it, simply click the Trend Reports icon located in the top navigation bar of the Lead Sheet, then select the graph type desired from the pull-down menu.

Drug Name Lookup:

  • To search by drug name, simply select Drug Name Lookup from the Search Type pull-down menu.

    PharmSource Lead Sheet Global Activity Report:

    Lead Type March 2015 2015 YTD
    Early Development 92 361
    Late Development 99 305
    Biologic 90 278
    Small Molecule 215 706
    Parenteral 88 336
    Oral 77 283
    New Financings 98 323
    Total Drug Leads 386 1291
    Total Device &
    Diagnostic Leads
    133 410

    *Total leads include acquisitions/alliances, company acquisition/alliances and events.


    Pipeline Tip

    Replicor completes enrollment in its Phase 2 proof-of-concept trial with REP 2139-Ca, a nucleic acid polymer in combination with Pegasys, pegintegeron alfa-2a, for the treatment of chronic hepatitis B/hepatitis D co-infection. Learn more.

    New Shortcuts to Targeted Opportunities

    by Katie Leuth, Senior Research Analyst

    We’ve made it faster and easier for you to visually identify specific types of new opportunities in the PharmSource Lead Sheet by adding an icon key. You’ll find this at the top of the weekly edition. Icons appear in the detail box for applicable individual leads.

    These icons provide shortcuts for you to three different types of new business opportunities… read on

    Follow the Money: Intercept Pharmaceuticals, Inc.

    Intercept Pharmaceuticals recently raised almost $367 million in the completion of a secondary public offering. The company depends upon Contract Research Organizations to conduct its clinical trials. Contract Development & Manufacturing Organizations should also take note that the company relies on CDMOs for API and finished product, and they currently do not have long-term or commercial agreements in place with third-party providers… read on.

    Sales Effectiveness: Manage Where it Counts

    What could President Abraham Lincoln’s Gettysburg Address possibly have to do with sales training? Delivered in only two minutes, this profoundly stirring speech is an object lesson in persuasiveness. In just ten sentences, Lincoln adeptly used effective selling skills to rouse and unify his audience:

    1) Tell a compelling and persuasive story: “Four score and seven years ago our fathers brought forth…”
    2) Find common ground and foster the idea of working together: “It is rather for us, the living, we here be dedicated to the great task remaining before us…” read on


    PharmSource President Jim Miller to Speak at INTERPHEX

    Topic: The Contract Services Market: 2015 Update
    Date: Wednesday, April 22nd
    Time: 11am
    Location: Pharmaceutical Technology/BioPharm Int’l Stage

    Learn more.


    PharmSource is pleased to be a media partner with Partnerships in Clinical Trials 2015.

    Date: April 22 to April 24
    Location: Boston, MA, USA

    Learn more.

    PharmSource Lead Sheet

    The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

    Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

    See for yourself how this resource can be a vital tool for building your brand and growing your market share.

    To request a test-drive today, contact Nathaniel Celentano at / 1-703-383-4903, ext. 112 (ET USA).